Update on Bladder Cancer Risk Factors
Emerging evidence links bladder cancer to pelvic radiation therapy, dietary factors, and gene-environment interactions.
Emerging evidence links bladder cancer to pelvic radiation therapy, dietary factors, and gene-environment interactions.
The increasing number of indications for second-generation antiandrogens may result in a large group of men at risk for toxic effects, according to investigators.
Study findings highlight the need for earlier mCSPC treatment intensification by urologists and oncologists.
The American Urologic Association advises caution in the use of anticholinergic medications to treat older or frail adults with OAB.
The risks for sudden cardiac death from certain QT-prolonging antibiotics increase with steeper serum to dialysate potassium gradients.
Monitoring and maintaining a higher tacrolimus trough level in the first month after transplantation is essential to avoid acute rejection, according to investigators.
NRG 0815 is a “landmark” study investigating the role of short-term androgen deprivation therapy added to modern, dose-escalated radiation to treat intermediate-risk prostate cancer.
Adverse events rates have been rising over time among patients receiving dialysis, investigators reported.
Colchicine use had declined 27% by 2019 compared with before the 2010 price increase.
As many as 1 in 4 patients receiving treatment for cancer and HIV may be at risk of experiencing drug-drug interactions, according to researchers.